---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-194472"
form_type: "8-K"
ticker: "SEPN"
cik: "0001984086"
company_name: "Septerna, Inc."
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:40:10.096043+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Septerna updates corporate presentation for investor meetings; no material new data disclosed

## Summary
- Updated corporate presentation dated September 2025 for use with investors and analysts.
- Presentation focuses on Septerna's GPCR drug discovery platform.
- No financial results, clinical data, or guidance changes were announced in the filing.

## SEC filing metadata
- accession: 0001193125-25-194472
- form_type: 8-K
- ticker: SEPN
- cik: 0001984086
- company_name: Septerna, Inc.
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1984086/000119312525194472/0001193125-25-194472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1984086/000119312525194472/d946079d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-194472
- JSON: https://secwatch.observer/filing/0001193125-25-194472.json
- Plain text: https://secwatch.observer/filing/0001193125-25-194472.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.